)

Lupin (500257) investor relations material
Lupin Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved double-digit year-over-year growth in revenue and profitability for Q1 FY26, with margin expansion and strong US and India performance, including record US revenues from Tolvaptan launch and multiple regulatory approvals.
Net income rose 52% year-over-year to ₹12,191 mn, with total comprehensive income reaching ₹13,816.8 mn.
Launched key products in the US, including Tolvaptan with sole first-to-file exclusivity, and completed strategic acquisitions and business transfers.
India region grew 7.8-8.6% year-over-year, with chronic therapies and respiratory franchise outpacing the market.
Other developed markets, especially Europe/EMEA, delivered robust growth, now accounting for a larger share of total sales.
Financial highlights
Q1 FY26 sales reached ₹62,683.4 million, up from ₹56,003.3 million year-over-year, with total income at ₹63,473.8 million.
US sales grew 23-24.3% year-over-year, reaching $282 million or ₹25,155 mn, with strong respiratory and specialty launches.
EBITDA margin improved to 26.6% (₹16,414 mn), up from 23.3% last year, and net cash stood at ₹1,239 crore as of June 30.
Gross margin improved to 71.3% from 68.4% year-over-year, driven by better product mix and cost efficiencies.
Net income for the quarter was ₹12,214.6 million, up from ₹8,055.4 million year-over-year.
Outlook and guidance
Reaffirmed full-year EBITDA margin guidance at 24-25%, with expectations of continued double-digit top-line growth for both the company and US segment.
Plans to launch 20+ products in India and file 15+ in the US in FY26, with a focus on complex generics and specialty products.
R&D spend expected to be 7.5-8.7% of sales for FY26.
Targeting 100+ new product launches and ~65% of NPL revenue from complex products by FY30.
High single-digit to double-digit growth targeted for FY27, with margin expansion supported by differentiated products and cost focus.
Next Lupin earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage